Reply to M. Sorigue et al

Grants

Funding Acknowledgements

Supported by the Cancer Council of Victoria, with additional funding contributed by the Australasian Leukaemia and Lymphoma Group, Peter MacCallum Cancer Centre, Amgen, and Roche. Roche also supplied the rituximab used in the amended version of the trial. Quality assurance for the trial was supported by a grant from the Australian Federal Department of Health.